Clinical Trials Browser

Gastrointestinal Neoplasms, Gastrointestinal Stromal Tumors

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Colonic Neoplasms, Colorectal Neoplasms

Pancreatic Neoplasms

Adenomatous Polyposis Coli, Polyps

Pancreatic Neoplasms

Carcinoma, Hepatocellular

Pancreatic Neoplasms

Neoplasms, Stomach Neoplasms

Biliary Tract Neoplasms

Advanced Gastroenteropancreatic Neuroendocrine Tumor

Hyperphagia, Stomach Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Neoplasm Metastasis, Pancreatic Neoplasms

Biliary Tract Neoplasms

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Pancreatic Neoplasms

Rectal Neoplasms

Locally Advanced Gastric or Gastroesophageal Junction Cancer

Rectal Neoplasms

Rectal Neoplasms

HER2-positive Gastric Cancer

Colorectal Neoplasms

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Carcinoma, Hepatocellular

Colorectal Neoplasms

Adenocarcinoma Of Esophagus

Colorectal Neoplasms

Colorectal Neoplasms

Colorectal Neoplasms

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Low Anterior Resection Syndrome, Rectal Neoplasms

Colorectal Neoplasms

Hepatoblastoma

Pancreatic Neoplasms

Carcinoma, Hepatocellular

Colonic Neoplasms

Pancreatic Neoplasms

Carcinoma, Hepatocellular

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

Gastro-enteropancreatic neuroendocrine tumor, Lymphoma, Follicular

Rectal Neoplasms

Advanced Colorectal Cancer

Rectal Neoplasms

Neoplasms, Colorectal Neoplasms

Esophageal Squamous Cell Carcinoma

Resectable Colon Cancer

Neoplasm Metastasis, Stomach Neoplasms

Clinical Trials

A Study of IDRX-42 (GSK6042981) Versus (vs) Sunitinib in Participants With Gastrointestinal Stromal Tumors After Imatinib Therapy

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

KANDLELIT-012

A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer

DAWN-303

SERENTA

Studying Chemotherapy With or Without Panitumumab for Unresectable, Locally Advanced, or Metastatic Pancreatic Cancer Without KRAS Mutations

HAIC vs. TACE Combined With Sintilimab and Bevacizumab for Intermediate HCC (Beyond Up-To-Seven)

Extending Outcomes for Pancreas Cancer Patients With Nominal Oligometastatic Disease (EXPAND): A Randomized Phase III Trial

BYQoL-GC

SAFIR-ABC10

An Open-label Phase 3 Study of Lutetium (177Lu) Oxodotreotide Injection in Subjects With Advanced Gastrointestinal Pancreatic Neuroendocrine Tumors.

PROGAIN

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

MAPKeeper 301

DESTINY-BTC01

Beacon-BTC

RASolute 303

A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer

Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer

RECTIL

NEO-RT

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

BATTMAN

Efficacy and Safety of Zanidatamab With Standard-of-care Therapy Against Standard-of-care Therapy for Advanced HER2-positive Biliary Tract Cancer

ARTEMIDE-HCC01

Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, The ERASur Study

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

OrigAMI-2

OrigAMI-3

A Study of Precemtabart Tocentecan With or Without Bevacizumab Compared to Trifluridine/Tipiracil Plus Bevacizumab in Participants With Previously Treated Metastatic Colorectal Cancer (PROCEADE-CRC-03)

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

iRECOVER

HARMONi-GI3

A Multi-institutional Study for Treatment of Children With Newly Diagnosed Hepatoblastoma Using a Modified PHITT Strategy

LAP100

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

Identification and Treatment Of Micrometastatic Disease in Stage III Colon Cancer

RASolute 304

UPGRADE

PD-1 Inhibitor Combined With Neoadjuvant Chemoradiotherapy Plus Surgery for Locally Advanced ESCC (NEOCRTEC2101)

NETTER-3

Neoadjuvant CAPOX With or Without Pucotenlimab Plus Selective Radiotherapy for Locally Advanced Rectal Cancer

FOLICOLOR

Neoadjuvant Radiotherapy for Rectal Adenocarcinoma With Capecitabine Versus TAS-102 (Neo-REACT): A Multi-center, Randomized, Phase III Trial

CodeBreaK 301

QLC5508 vs. Chemotherapy in Pretreated Advanced or Metastatic Esophageal Squamous Cell Carcinoma

Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

CIME